DalsnaFinance

Lifemd Inc $LFMD

Health Care

Russell 2000 New York
Create a scorecard
$2.25
-0.01 (-0.22%)
As of Oct 20, 2026, 5:56 PM EDT · cached
Price history
Loading chart…

Lifemd Inc (LFMD) is trading down at $2.25 (-0.22%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

Lifemd Inc revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$194.1M$66.6M−$60.9MFY2016 revenue: $5.24MFY2016 net income: −$1.11M · Net margin −21.1%'16FY2017 revenue: $5.00MFY2017 net income: −$1.21M · Net margin −24.1%'17FY2018 revenue: $8.32MFY2018 net income: −$1.24M · Net margin −14.9%'18FY2019 revenue: $12.5MFY2019 net income: −$3.14M · Net margin −25.2%'19FY2020 revenue: $37.3MFY2020 net income: −$58.6M · Net margin −157.3%'20FY2021 revenue: $92.9MFY2021 net income: −$60.9M · Net margin −65.6%'21FY2022 revenue: $119.0MFY2022 net income: −$45.5M · Net margin −38.3%'22FY2023 revenue: $152.5MFY2023 net income: −$20.6M · Net margin −13.5%'23FY2024 revenue: $154.8MFY2024 net income: −$21.4M · Net margin −13.8%'24FY2025 revenue: $194.1MFY2025 net income: $14.4M · Net margin 7.4%'25−6.3%0%10%20%FY2016 net margin: −21.1% (off the scale, which stops at −6.3%)FY2017 net margin: −24.1% (off the scale, which stops at −6.3%)FY2018 net margin: −14.9% (off the scale, which stops at −6.3%)FY2019 net margin: −25.2% (off the scale, which stops at −6.3%)FY2020 net margin: −157.3% (off the scale, which stops at −6.3%)FY2021 net margin: −65.6% (off the scale, which stops at −6.3%)FY2022 net margin: −38.3% (off the scale, which stops at −6.3%)FY2023 net margin: −13.5% (off the scale, which stops at −6.3%)FY2024 net margin: −13.8% (off the scale, which stops at −6.3%)FY2025 net margin: 7.4%
Lifemd Inc annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$5.24M$5.00M$8.32M$12.5M$37.3M$92.9M$119.0M$152.5M$154.8M$194.1M
Growth (year over year)+329.8%−4.6%+66.5%+49.8%+199.1%+149.0%+28.2%+28.2%+1.5%+25.3%
Gross profit$3.29M$2.66M$6.33M$9.94M$28.4M$74.9M$100.4M$133.6M$133.4M$166.3M
Gross margin62.9%53.3%76.0%79.7%76.2%80.6%84.3%87.6%86.2%85.7%
Operating income−$1.17M−$1.23M−$2.06M−$2.89M−$57.8M−$54.3M−$43.4M−$14.5M−$20.4M−$7.67M
Operating margin−22.4%−24.6%−24.7%−23.2%−155.0%−58.5%−36.5%−9.5%−13.2%−4.0%
Net income−$1.11M−$1.21M−$1.24M−$3.14M−$58.6M−$60.9M−$45.5M−$20.6M−$21.4M$14.4M
Net margin−21.1%−24.1%−14.9%−25.2%−157.3%−65.6%−38.3%−13.5%−13.8%7.4%
EPS (diluted)−$0.03−$0.03——————−$0.60$0.25
Balance sheet
Cash and equivalents$182.6K$141.4K$180.1K$1.11M$9.18M$41.3M$3.96M$33.1M$35.0M$36.8M
Total assets$789.8K$1.26M$2.62M$3.45M$13.4M$49.9M$25.7M$58.5M$76.1M$70.4M
Total liabilities$1.15M$641.0K$1.80M$4.58M$14.2M$24.1M$33.0M$52.9M$83.7M$47.3M
Shareholders' equity−$355.2K$881.9K$897.7K−$988.2K−$2.30M$22.7M−$11.4M$3.51M−$9.08M$23.2M
Cash flow
Operating cash flow−$407.9K−$817.2K−$905.5K$251.4K−$12.1M−$33.1M−$22.9M$8.82M$17.5M$8.28M
Capital expenditure—————$247.4K$366.6K$203.8K$1.46M$1.87M
Free cash flow—————−$33.3M−$23.3M$8.62M$16.0M$6.41M
Dividends paid—————$871.5K$3.11M$3.11M$3.11M$3.11M
Share buybacks—$76.6K———————$270.0K

From Lifemd Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Lifemd Inc

Headquarters
New York, New York From SEC filings, Oct 2026

Recent News (2)

More Health Care stocks

Browse all companies →